Global Pen Needles Market New Report by Data Bridge Market Research

databridgemarketresearch.com presents "Global Pen Needles Market 2017.” It has accounted for USD 1.9 billion in 2016, and is expected to reach USD 4.5 billion by 2024 growing at a CAGR of 11.6% in the forecast period of 2017 to 2024.

Dallas, TX, May 21, 2017 --(PR.com)-- The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

The Global Pen Needles Market is segmented on the basis of product type, product length, Usability, application, therapy, end-user and geography.

Request for sample pages: http://databridgemarketresearch.com/reports/global-pen-needles-market/

The global pen needle market is segmented based on product type into standard and safety pen needles.

The pen needles market is also segmented based on product length which varies from 4mm to 13mm in size. The pen needles segment by product length is long length, medium length and Nano length needles.

Based on usability the global pen needles market is segmented into disposable and reusable pen needles.

On the basis of application the global pen needles market is segmented into 3 indications diabetes, growth hormone deficiency and others.

Based on the drug therapy the pen needles market is segmented into insulin, glucagon-like peptide-1 and growth hormones.

Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.

Read more: http://databridgemarketresearch.com/global-pen-needles-market-expected-reach-usd-3-6/

The major players operating in this market Becton, Dickinson and Company, ADW Diabetes, Novo Nordisk, A.Menarini Diagnostics, Ulticare, Ypsomed Holding AG, Facet Technologies, B. Braun Melsungen AG, Shanghai Neo-Medical Co. Ltd, HTL-Strefa S.A., Frank Healthcare Co., Ltd, Stat Medical Devices, Inc., Terumo Corporation, Domrex Pharma Inc., Vogt Medical Vertrieb GmbH, Artsana S.p.a, Eli Lilly, Owen Mumford Ltd, KD Medical GmbH Hospital Products, Allison Medical, Inc., Digital Medics Pty Ltd, and Ultimed, Inc. among others.

About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact
Data Bridge Market Research
Varsha Chaudhari
+1-888-387-2818
http://databridgemarketresearch.com
Visit Data Bridge Blog @ http://databridgemarketresearch.com/blog/
ContactContact
Categories